Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
featured
Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

  • 2074 views
  • 08 Nov, 2020
  • 1 location
featured
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that becomes worse over time. There is currently no effective treatment for it. Researchers

idiopathic pulmonary fibrosis
chest ct
x-rays
chest x-ray
ct scan
  • 162 views
  • 23 Nov, 2020
  • 1 location
featured
A Trial to Assess the Safety Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

of Rotarix/placebo PO at monthly intervals starting at 6 to <8 weeks of age, administered concomitantly with EPI/UIP vaccines. To maintain the blind, infants allocated to the TV P2-VP8 vaccine arm

  • 0 views
  • 15 Apr, 2021
  • 1 location
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive, and fibrotic lung disease. It has been considered rare, with an incidence estimated to 11.5 cases per 100 000

  • 0 views
  • 09 May, 2021
  • 1 location
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

pamrevlumab
pirfenidone
idiopathic pulmonary fibrosis
carbon monoxide
nintedanib
  • 0 views
  • 14 Jun, 2021
  • 54 locations
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.

pirfenidone
idiopathic pulmonary fibrosis
carbon monoxide
forced vital capacity
nintedanib
  • 384 views
  • 29 May, 2021
  • 142 locations
Safety Efficacy and Pharmacokinetics of C21 in Subjects With IPF

This trial is a multi-centre, open-label, single-arm phase 2 trial investigating the safety, efficacy and pharmacokinetics of C21 in subjects with idiopathic pulmonary fibrosis.

  • 0 views
  • 04 Apr, 2021
  • 20 locations
High Intensity Interval Training in Fibrotic Interstitial Lung Disease

The fibrotic interstitial lung diseases (fILD) is a group of debilitating chronic lung conditions that are characterised by scarring of lung tissue, dyspnoea on exertion and significant physical impairment. Exercise training is recommended for people with fILD in improving breathlessness and exercise tolerance. However, despite the best efforts of patients …

  • 7 views
  • 09 Mar, 2021
  • 4 locations
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial

The fibrotic interstitial lung diseases (fILD) are characterised by lung scarring, distressing breathlessness and poor health-related quality of life. Exertional desaturation (low blood oxygen during exercise) is a hallmark of fILD, occurring in over 50% of patients. It is sometimes treated with ambulatory oxygen therapy (AOT), which involves breathing supplemental …

  • 3 views
  • 08 Mar, 2021
  • 2 locations